109 related articles for article (PubMed ID: 11730721)
21. Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
Ohtomo T; Saito H; Inotsume N; Yasuhara M; Inui KI
J Pharmacol Exp Ther; 1996 Mar; 276(3):1143-8. PubMed ID: 8786545
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells.
Hirano T; Yasuda S; Osaka Y; Kobayashi M; Itagaki S; Iseki K
Biochim Biophys Acta; 2006 Nov; 1758(11):1743-50. PubMed ID: 16928358
[TBL] [Abstract][Full Text] [Related]
23. Identification of influx transporter for the quinolone antibacterial agent levofloxacin.
Maeda T; Takahashi K; Ohtsu N; Oguma T; Ohnishi T; Atsumi R; Tamai I
Mol Pharm; 2007; 4(1):85-94. PubMed ID: 17274666
[TBL] [Abstract][Full Text] [Related]
24. Human THP-1 monocyte uptake and cellular disposition of 14C-grepafloxacin.
Hall IH; Schwab UE; Ward ES; Rublein JC; Butts JD; Ives TJ
J Infect Chemother; 2004 Feb; 10(1):11-8. PubMed ID: 14991512
[TBL] [Abstract][Full Text] [Related]
25. Carrier-mediated uptake of grepafloxacin, a fluoroquinolone antibiotic, by the isolated rat lung cells.
Sasabe H; Kato Y; Suzuki T; Itose M; Miyamoto G; Sugiyama Y
Drug Metab Pharmacokinet; 2005 Dec; 20(6):491-5. PubMed ID: 16415534
[TBL] [Abstract][Full Text] [Related]
26. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
Sasabe H; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
[TBL] [Abstract][Full Text] [Related]
27. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
Sasabe H; Kato Y; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
[TBL] [Abstract][Full Text] [Related]
28. Primary active transport of organic anions on bile canalicular membrane in humans.
Niinuma K; Kato Y; Suzuki H; Tyson CA; Weizer V; Dabbs JE; Froehlich R; Green CE; Sugiyama Y
Am J Physiol; 1999 May; 276(5):G1153-64. PubMed ID: 10330006
[TBL] [Abstract][Full Text] [Related]
29. Regulation of fluoroquinolone uptake by human neutrophils: involvement of mitogen-activated protein kinase.
Hotta K; Niwa M; Hirota M; Kanamori Y; Matsuno H; Kozawa O; Otsuka T; Matsui N; Uematsu T
J Antimicrob Chemother; 2002 Jun; 49(6):953-9. PubMed ID: 12039887
[TBL] [Abstract][Full Text] [Related]
30. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Klepser ME; Ernst EJ; Petzold CR; Rhomberg P; Doern GV
Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
[TBL] [Abstract][Full Text] [Related]
31. Kinetic modelling of the intestinal transport of sarafloxacin. Studies in situ in rat and in vitro in Caco-2 cells.
Fernandez-Teruel C; Gonzalez-Alvarez I; Casabó VG; Ruiz-Garcia A; Bermejo M
J Drug Target; 2005 Apr; 13(3):199-212. PubMed ID: 16036308
[TBL] [Abstract][Full Text] [Related]
32. Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
Zhao YL; Cai SH; Wang L; Kitaichi K; Tatsumi Y; Nadai M; Yoshizumi H; Takagi K; Takagi K; Hasegawa T
Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):167-72. PubMed ID: 11906478
[TBL] [Abstract][Full Text] [Related]
33. Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies.
Rodríguez-Ibáñez M; Nalda-Molina R; Montalar-Montero M; Bermejo MV; Merino V; Garrigues TM
Eur J Pharm Biopharm; 2003 Mar; 55(2):241-6. PubMed ID: 12637104
[TBL] [Abstract][Full Text] [Related]
34. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
35. Differential uptake of grepafloxacin by human circulating blood neutrophils and those exudated into tissues.
Niwa M; Hotta K; Kanamori Y; Matsuno H; Kozawa O; Hirota M; Uematsu T
Eur J Pharmacol; 2001 Sep; 428(1):121-6. PubMed ID: 11779028
[TBL] [Abstract][Full Text] [Related]
36. Transepithelial transport of levofloxacin in the isolated perfused rat kidney.
Ito T; Yano I; Hashimoto Y; Inui K
Pharm Res; 2000 Feb; 17(2):236-41. PubMed ID: 10751041
[TBL] [Abstract][Full Text] [Related]
37. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat.
Sasabe H; Terasaki T; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):162-71. PubMed ID: 9223551
[TBL] [Abstract][Full Text] [Related]
38. [Uptake of 5 fluoroquinolones into human polymorphonuclear cells].
Ballesta S; Pascual A; García I; Perea EJ
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):470-3. PubMed ID: 9011203
[TBL] [Abstract][Full Text] [Related]
39. The comparative arthropathy of fluoroquinolones in dogs.
Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
[TBL] [Abstract][Full Text] [Related]
40. Mechanism for the tissue distribution of grepafloxacin, a fluoroquinolone antibiotic, in rats.
Suzuki T; Kato Y; Sasabe H; Itose M; Miyamoto G; Sugiyama Y
Drug Metab Dispos; 2002 Dec; 30(12):1393-9. PubMed ID: 12433809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
